SCHEMBL3607426

SCHEMBL3607426

CCc1c(C)nn(C)c1Sc1cc(O[C@@H](C)C(=O)O)c(Cl)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
RAB9A P51151 1/20 0.35
S1PR1 P21453 2/20 0.34
SHMT2 P34897 1/20 0.34
PPARG P37231 5/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.32
KMO O15229 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TTR P02766 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605174 0.87 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3614207 0.86 PTGDR2 (0.39) GAATSHRHTR2AHTR2CHTR2B
SCHEMBL3599634 0.85 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3606716 0.85 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3606243 0.84 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3599746 0.84 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3603499 0.84 ALDH1A1 (0.38) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3601746 0.83 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3615618 0.83 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL3613880 0.81 ALDH1A1 (0.36) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885KDM4E 2049/4885HSD17B10 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.